23rd,2025
Plenary Talk 1
--------------------------------------------------------------------------------------------------------
Jillian Sarah Gauld, Gates Foundation, USA
Symposium 1
Infectious Diseases Surveillance and Modeling in LMIC’s:
Wastewater-Based Epidemiology
--------------------------------------------------------------------------------------------------------
Joshua Levy, Scripps Research, USA
Alex Shaw, Imperial College London, UK
Mukhlid Yousif, National Institute for Communicable Diseases (NICD), South Africa / Department of Virology, School of Pathology, Faculty of Health Sciences, University of Witwatersrand, South Africa
Benjamin Fuller, University of Virginia, USA
Josh M Colston, The University of Virginia School of Medicine, USA
Symposium 2
Durability and Senescence of immune response
--------------------------------------------------------------------------------------------------------
Sydney Ramirez, La Jolla Institute for Immunology, USA / University of California, San Diego, USA
Yoshimasa Takahashi, Japan Institute for Health Security, National Institute of Infectious Diseases, Japan
Yoko Hamazaki, Center for iPS Cell Research and Application, Graduate School of Medicine, Kyoto University, Japan / Laboratory of Immunobiology, Graduate School of Medicine, Kyoto University, Japan
Shunya Tsuji, Laboratory of Veterinary Pharmacology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Japan
Kenji Chamoto, Department of Cancer Immunology and Photodynamic Therapy, Graduate School of Medicine, Kyoto University, Japan
David Geoffrey Priest, Human Single Cell Immunology Team, Division of Microbiology and Immunology, Center for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, Japan
Symposium 3
Dissecting the Molecular Mechanisms of Virus–Host Interactions
--------------------------------------------------------------------------------------------------------
Thomas Hoenen, Friedrich-Loeffler-Institute, Germany
Juan Martin-Serrano, Department of Infectious Diseases, Faculty of Life Sciences & Medicine, King's College London, UK
Allison Groseth, Friedrich-Loeffler-Institute, Germany
Takeshi Ichinohe, Institute of Medical Science, The University of Tokyo, Japan
Yusuke Ohba, Department of Cell Physiology, Faculty of Medicine, Hokkaido University, Japan
Shuhei Higuchi, Arase Lab, Center for Advanced Modalities and DDS (CAMaD), Osaka University, Japan
WenChing Luo, Graduate School of Biostudies, Kyoto University, Japan / Institute for Life and Medical Sciences, Kyoto University, Japan
Plenary Talk 2
--------------------------------------------------------------------------------------------------------
Kim Mulholland, Murdoch Children’s Research Institute, Melbourne, Australia London School of Hygiene and Tropical Medicine, UK
Symposium 4
Reevaluation of Existing Vaccines and Policies
--------------------------------------------------------------------------------------------------------
Lay-Myint Yoshida, Institute of Tropical Medicine, Nagasaki University, Japan
Konosuke Morimoto, Institute of Tropical Medicine, Nagasaki University, Japan
Motoi Suzuki, Japan Institute for Health Security, Japan
Pilailuk Akkapaiboon Okada, National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Thailand
Hoan T Pham, Institute of Tropical Medicine, Nagasaki University, Japan
Augustin Tshibaka Kabongo, School of Tropical Medicine and Global Health,Nagasaki University, Japan / Institute of Tropical Medicine (NEKKEN), Nagasaki University, Japan / Faculty of Medicine, Public Health and Pharmacy, University of Mbujimayi, Democratic Republic of the Congo
Educational lecture
Vaccine Development Using Different Regulatory Pathways
--------------------------------------------------------------------------------------------------------
Kawsar Talaat, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, USA
Symposium 5
Vaccine Development for Leishmaniasis
--------------------------------------------------------------------------------------------------------
Hayato Urabe, Global Health Innovative Technology Fund, Japan
Greg Matlashewski, McGill University, Canada
Abhay R Satoskar, Department of Microbiology and Immunology, McGill University, Montreal, Canada / Department of Pathology and Microbiology, Ohio State University, Columbus, OH, USA
Hira Nakhasi, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, USA
Shaden Kamhawi, National Institutes of Health, USA
Sanjay Singh, Gennova Biopharmaceuticals, Hinjawadi Phase II, Pune, Maharashtra, India
Kawsar Talaat, Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, USA
3 Short Talks
Other pathogens/ infections
--------------------------------------------------------------------------------------------------------
Eizo Takashima, Division of Malaria Research, Proteo-Science Center, Ehime University, Japan
Anjali Satoskar, The Ohio State University Medical Center, USA
Shu Nakamura, Obihiro University of Agriculture and Veterinary Medicine, Japan
Plenary Talk 3
--------------------------------------------------------------------------------------------------------
Ken J Ishii, Division of Vaccine Science, The Institute of Medical Science, The University of Tokyo (IMSUT), Japan / International Vaccine Design Center,IMSUT, Japan / UTOPIA, The University of Tokyo, Japan
Symposium 6
New Modalities for Next-Generation Vaccines
--------------------------------------------------------------------------------------------------------
Ali Ellebedy, Washington University School of Medicine, USA
Wataru Akahata, VLP Therapeutics, Inc., USA / VLP Therapeutics Japan, Inc., Japan
Xiawei Wei, West China Hospital, Sichuan University, China
Dongyun Lu, Department of Immunology, Graduate School of Medicine, Kyoto University, Japan / Kyoto Immunomonitoring Center (KIC), Japan
Satoshi Uchida, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo, Japan / Innovation Center of NanoMedicine (iCONM), Kawasaki Institute of Industrial Promotion, Japan